References
- Witschi HR, Haschek WM, Klein-Szanto A JP, Hakkinen PJ. Potentiation of diffuse lung damage by oxygen: determining variables. Am Rev Respir Dis. 1981; 123: 98–103
- Fox RB, Hoidal JR, Brown DM, Repine JE. Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am Rev Respir Dis. 1981; 123: 521–523
- Shasby DM, Fox RB, Harada RN, Repine JE. Reduction of the edema of acute hyperoxic lung injury by granulocyte depletion. J Appl Physiol. 1982; 52: 1237–1244
- Raj JU, Hazinski TA, Bland RD. Oxygen-induced lung microvascular injury in neutropenic rabbits and lambs. J Appl Physiol. 1985; 58: 921–927
- Brain JD. Lung macrophages: how many kinds are there. What do they do? Am Rev Respir Dis. 1988; 137: 507–509
- Stephens KE, Ishizaka A, Larrick JW, Raffin TA. Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis. 1988; 137: 1364–1370
- Marcho Z, White JE, Higgins PJ, Tsan MF. Tumor necrosis factor enhances endothelial cell susceptibility to oxygen toxicity: role of glutathione. Am J Respir Cell Mol Biol 1991; 5: 556–562
- Jensen JC, Pogrebniak HW, Pass HI. Role of tumor necrosis factor in oxygen toxicity. J Appl Physiol. 1992; 72: 1902–1907
- Tsan MF, White JE, Santana TA, Lee CY. Tracheal insufflation of tumor necrosis factor protects rats against oxygen toxicity. J Appl Physiol. 1990; 68: 1211–1219
- Tsan MF, Lee CY, White JE. Interleukin 1 protects rats against oxygen toxicity. J Appl Physiol. 1991; 71: 688–697
- White CW, Ghezzi P, Dinarello CA, Caldwell SA, McMurty IF, Repine JE. Recombinant tumor necrosis factor/cachectin and interleukin 1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia. J Clin Invest. 1987; 79: 1868–1873
- Tsan MF, Lawrence D, White JE. Erythrocyte insufflation-induced protection against oxygen toxicity: role of cytokines. J Appl Physiol. 1991; 71: 1751–1757
- Berg JT, Lee ST, Thepen T, Lee CY, Tsan MF. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. J Appl Physiol. 1993; 74: 2812–2819
- Van Rooijen N. The liposome-mediated macrophage ‘suicide’ technique. J Immunol Methods 1989; 124: 1–6
- Classen E, Van Rooijen N. Preparation and characteristics of dichloromethylene diphosphonate-containing liposomes. J Microencaps. 1986; 3: 109–114
- Berg JT, Allison RC, Prasad PR, Taylor AE. Endotoxin protection of rats from pulmonary oxygen toxicity: possible cytokine involvement. J Appl Physiol. 1990; 68: 549–553
- Smith PK, Krohn RI, Hermanson GT. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150: 76–85
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457–481
- Stuart A, Ord JK. Kendall's Advanced Theory of Statistics, 5th ed. Oxford University Press, New York 1987; 165–166
- Davis WB, Rennard SI, Bitterman PB, Crystal RG. Pulmonary oxygen toxicity: early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med. 1983; 309: 878–883
- Griffith DE, Garcia J GN, James HL, Callahan KS, Iriana S, Holiday D. Hyperoxic exposure in humans: effects of 50 percent oxygen on alveolar macrophage leukotriene B4 synthesis. Chest 1992; 101: 392–397
- Harada RN, Vatter AE, Repine JE. Macrophage effector function in pulmonary oxygen toxicity: hyperoxia damages and stimulates alveolar macrophages to make and release chemotaxin for polymorphonuclear leukocytes. J Leuk Biol. 1984; 35: 373–383
- Smith RM, Mohideen P. One hour in 1 ATA oxygen enhances rat alveolar macrophage chemiluminescence and fungal cytotoxicity. Am J Physiol. 1991; 260(4)L457–L463
- Forman HJ, Williams JJ, Nelson J, Daniele RP, Fisher AB. Hyperoxia inhibits stimulated superoxide release by rat alveolar macrophages. J Appl Physiol. 1982; 53: 685–689
- Murphey SA, Hyams JS, Fisher AB, Root RK. Effects of oxygen exposure on in vitro function of pulmonary alveolar macrophages. J Clin Invest. 1975; 56: 503–511